|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ChiCTR |
|
Last refreshed on:
|
18 April 2017 |
|
Main ID: |
ChiCTR-INR-17010434 |
|
Date of registration:
|
2017-01-15 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Randomized controlled study for the anatomic transurethral enucleation of the prostate and transurethral resection of the prostate for the treatment of benign prostatic hyperplasia
|
|
Scientific title:
|
Randomized controlled study for the anatomic transurethral enucleation of the prostate and transurethral resection of the prostate for the treatment of benign prostatic hyperplasia |
|
Date of first enrolment:
|
2017-01-10 |
|
Target sample size:
|
HoLEP:157;PVP:157; |
|
Recruitment status: |
Recruiting |
|
URL:
|
http://www.chictr.org.cn/showproj.aspx?proj=17552 |
|
Study type:
|
Interventional study |
|
Study design:
|
Randomized parallel controlled trial
|
|
Phase:
|
New Treatment Measure Clinical Study
|
|
|
Countries of recruitment
|
|
China
| | | | | | | |
|
Contacts
|
|
Name:
|
Xu Huan
|
|
Address:
|
639 Zhizaoju Road, Shanghai, China
|
|
Telephone:
|
+86 18221683312 |
|
Email:
|
xuhuaneric@hotmail.com |
|
Affiliation:
|
Shanghai 9th People's Hospital, Shanghai Jiaotong University School of Medicine |
|
|
Name:
|
Wang Zhong
|
|
Address:
|
639 Zhizaoju Road, Shanghai, China
|
|
Telephone:
|
+86 13301980998 |
|
Email:
|
zhongwang2000@sina.com |
|
Affiliation:
|
Shanghai 9th People's Hospital, Shanghai Jiaotong University School of Medicine |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: 1. More than 2 times of urine retention; Residual urine>100ml;
2. Poor effect of the use of 5ARI and a-receptor blocker and IPSS>15;
3. Urinary tract infection and bladder stones or the bladder disfunction caused by the BPH;
4. Archoptoma,hydronephrosis,inguinal hernia,haemorrhoids,bladder diverticula or urinary infection combined with the BPH.
5. 30ml=prostate volume=80ml
Exclusion criteria: 1. Qmax>20ml/s;
2. Neurogenic bladder;
3. Injuries in the low urinary tract and the prostate;
4. Bladder cancer or the prostate cancer during our treatment or the follow up;
5. Structures in the urinary tract and bladder neck.
Age minimum:
Age maximum:
Gender:
Male
|
|
Health Condition(s) or Problem(s) studied
|
|
benign prostatic hyperplasia
|
|
Intervention(s)
|
|
HoLEP:HoLEP;PVP:PVP;
|
|
Primary Outcome(s)
|
|
perioperative data;follow-up data;patients' characteristics;
|
|
Source(s) of Monetary Support
|
|
self-financing
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|